top of page

Insync increase exposure to global healthcare

Updated: Jan 15, 2024


Insync has increased its Medtronics position to be largest holding in its portfolio.

“The slowdown in China will have relatively minimal impact on the outlook for Medtronics which is benefitting from the powerful megatrend in the growing demand for healthcare products and services and through innovation,’ said Monik Kotecha, Insync Funds Management.

Photo by Medtronic

In a low global growth environment Insync Funds Management is still finding opportunities in the global healthcare sector. Whilst global GDP is forecast to grow at around 2-3%, and there are growing concerns the slowdown in China will further negatively impact the global economy, Insync is finding opportunities in the global healthcare which they forecast to grow at a pace of 2x GDP over the coming years.

Insync finds the global healthcare sector has characteristics it seeks in exceptional businesses:

  • including high levels of profitability

  • strong free cash generation, and

  • strong capital allocation back to shareholders in the form of rising dividends and buybacks.

In the recent market volatility Insync added to its position in Medtronics, the leading medical device company in the world.

“Medtronics is extremely well diversified across different products and geographies and has leadership positions in cardiology, general surgery, vascular, neurology, spine, and diabetes markets.”

The company is forecast to generate free cash flow of over $7bn in 2016 and is committed to returning 50% of its free cash flow to shareholders in the form of growing dividends and buybacks. The slowdown in China will have relatively minimal impact on the outlook for Medtronics which is benefitting from the powerful megatrend in the growing demand for healthcare products and services and through innovation. The recent volatility in global markets provided Insync the opportunity to increase it’s holding in Medtronics.

Insync manages a concentrated portfolio of 15-30 exceptional global companies in the Insync Global Titan’s Fund with Medtronics now the Fund’s largest holding.


16 views0 comments

Recent Posts

See All
  • linkedin
  • YouTube Social  Icon

Equity Trustees Limited (“EQT”) (ABN 46 004 031 298), AFSL 240975, is the Responsible Entity for the Insync Global Quality Fund and the Insync Global Capital Aware Fund.  EQT is a subsidiary of EQT Holdings Limited (ABN 22 607 797 615), a publicly listed company on the Australian Securities Exchange (ASX: EQT).  This information has been prepared by Insync Funds Management Pty Ltd (ABN 29 125 092 677, AFSL 322891) (“Insync”), to provide you with general information only. In preparing this information, we did not take into account the investment objectives, financial situation or particular needs of any particular person. It is not intended to take the place of professional advice and you should not take action on specific issues in reliance on this information. Neither Insync, EQT nor any of its related parties, their employees or directors, provide and warranty of accuracy or reliability in relation to such information or accepts any liability to any person who relies on it. Past performance should not be taken as an indicator of future performance. You should obtain a copy of the Product Disclosure Statement before making a decision about whether to invest in this product.

©2018 by Insync Funds Management Pty Ltd.

Disclaimer

bottom of page